PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Actogenix
Actogenix is a proprietary peptide-bioregulator-style product marketed for vitality, energy, and healthy-aging support. It is sold as a research chemical with limited published data.
Sign in to rate this peptide.
Actogenix is positioned within the Khavinson-style short peptide bioregulator tradition, in which ultrashort peptides are proposed to bind regulatory regions of DNA and modulate tissue-specific gene expression. The marketed rationale centers on supporting cellular energy metabolism, mitochondrial function, and adaptive (actoprotector-like) resistance to physical and oxidative stress. Because its specific sequence and targets are not published in peer-reviewed sources, the mechanism remains inferred from the bioregulator and actoprotector classes rather than direct evidence.